Jim Simons's position in Ultragenyx Pharmaceutical is currently worth $9.16 Million. That's 0.01% of their equity portfolio (967th largest holding). The first Ultragenyx Pharmaceutical trade was made in Q3 2015. Since then Jim Simons bought shares seven more times and sold shares on six occasions. The investor's estimated purchase price is $12.8 Million, resulting in a loss of 29%.